Rationality and the generalization of randomized controlled trial evidence

Journal of Evaluation in Clinical Practice

Volumn 19, Issue 4, 2013, Pages 644-647

  Fuller, Jonathan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY; EXTERNAL VALIDITY; HUMAN; INTERNAL VALIDITY; MEDICAL LITERATURE; NOTE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE;

HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84881163056     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12021     Document Type: Note

References (43)

1. Bluhm, R., &, Borgerson, K., (2011) Evidence-based medicine. In Handbook of the philosophy of science: volume 16: philosophy of medicine (eds, D. M. Gabbay, P. Thagard, &, J. Woods,), pp. 203-238. Amsterdam: Elsevier.
2. Guyatt, G., Rennie, D., Meade, M. O., &, Cook, D. J., (2008) Users' guides to the medical literature: essentials of evidence-based clinical practice, 2nd edn. New York: McGraw-Hill Medical.
3. Rothwell, P. M., (2005) External validity of randomised controlled trials: 'to whom do the results of this trial apply?'. Lancet, 365 (9453), 82-93.
4. Hampton, J. R., (2002) Size isn't everything. Statistics in Medicine, 21 (19), 2807-2814.
5. Bluhm, R., (2007) Clinical trials as nomological machines: implications for evidence-based medicine. In Establishing medical reality: essays in the metaphysics and epistemology of biomedical science (eds, H. Kincaid, &, J. McKitrick,), pp. 149-166. Dordrecht: Springer.
6. Cartwright, N., (2007) Are RCTs the gold standard? BioSocieties, 2 (1), 11-20.
7. Feinstein, A. R., &, Horwitz, R. I., (1997) Problems in the 'evidence' of 'evidence-based medicine'. American Journal of Medicine, 103 (6), 529-535.
8. Black, D., (1998) The limitations of evidence. Perspectives in Biology and Medicine, 42 (1), 1-7.
9. Campbell-Scherer, D., (2010) Multimorbidity: a challenge for evidence-based medicine. Evidence-Based Medicine, 15 (6), 165-166.
10. Fortin, M., Dionne, J., Pinbo, G. V., Gignac, J., Almirall, J., &, Lapointe, L., (2006) Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Annals of Family Medicine, 4 (2), 104-108.
11. Tinetti, M. E., Bogardus, S. T., &, Agostini, J. V., (2004) Potential pitfalls of disease-specific guidelines for patients with multiple conditions. New England Journal of Medicine, 351 (27), 2870-2874.
12. Rawlins, M., (2008) De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet, 372 (9656), 2152-2161.
13. Black, N., (1996) Why we need observational studies to evaluate the effectiveness of health care. British Medical Journal, 312 (7040), 1215-1218.
14. Van Spall, H. G. C., Toren, A., Kiss, A., &, Fowler, R. A., (2007) Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. Journal of the American Medical Association, 297 (11), 1233-1240.
15. Fortin, M., Bravo, G., Hudon, C., Vanasse, A., &, Lapointe, L., (2005) Prevalence of multimorbidity among adults seen in family practice. Annals of Family Medicine, 3 (3), 223-228.
16. Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., &, Guthrie, B., (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet, 380 (9836), 37-43.
17. Salisbury, C., Johnson, L., Purdy, S., Valderas, J. M., &, Montgomery, A. A., (2011) Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. British Journal of General Practice, 61 (582), e12-e21.
18. Guthrie, B., Payne, K., Alderson, P., McMurdo, M. E. T., &, Mercer, S. W., (2012) Adapting clinical guidelines to take account of multimorbidity. British Medical Journal, 345, e6341.
19. Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., &, Wu, A. W., (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. Journal of the American Medical Association, 294 (6), 716-724.
20. Goulding, M. R., Rogers, M. E., &, Smith, S. M., (2003) Public health and aging: trends in aging-United States and worldwide. Journal of the American Medical Association, 289 (11), 1371-1373.
21. Jadad, A. R., Cabrera, A., Martos, F., Smith, R., &, Lyons, R. F., (2010) When people live with multiple chronic diseases: a collaborative approach to an emerging global challenge. Granada: Andalusian School of Public Health.
22. Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., &, Lindau, S. T., (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. Journal of the American Medical Association, 300 (24), 2867-2878.
23. Hanley, G. E., &, Morgan, S., (2009) Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social Science & Medicine, 68 (5), 919-924.
24. Sackett, D. L., &, Rennie, D., (1992) The science of the art of the clinical examination. Journal of the American Medical Association, 267 (19), 2650-2652.
25. Upshur, R. E. G., (2005) Looking for rules in a world of exceptions: reflections on evidence-based practice. Perspectives in Biology and Medicine, 48 (4), 477-489.
26. Post, P. N., de Beer, H., &, Guyatt, G. H., (2013) How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches. Journal of Evaluation in Clinical Practice, 19 (4), 638-643.
27. Oxman, A. D., Cook, D. J., &, Guyatt, G. H., (1994) Users' guides to the medical literature. VI. How to use an overview. Journal of the American Medical Association, 272 (17), 1367-1371.
28. Dans, A. L., Dans, L. F., Guyatt, G. H., &, Richardson, S., (1998) Users' guides to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patient. Journal of the American Medical Association, 279 (7), 545-549.
29. Guyatt, G., &, Rennie, D., (2001) User's guide to the medical literature. Chicago, IL: AMA Press.
30. Furukawa, T. A., Guyatt, G. H., &, Griffith, L. E., (2002) Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. International Journal of Epidemiology, 31 (1), 72-76.
31. Deeks, J. J., (2002) Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine, 21 (11), 1575-1600.
32. Turnbull, F., Neal, B., Ninomiya, T., et al. (2008) Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials. British Medical Journal, 336 (7653), 1121-1123.
33. Hlatky, M. A., Boothroyd, D. B., Bravata, D. M., et al. (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet, 373 (9670), 1190-1197.
34. Pignon, J., P., le Maitre, A., Maillard, E., &, Bourhis, J., (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology, 92 (1), 4-14.
35. Weiss, N. S., Koepsell, T. D., &, Psaty, B. M., (2008) Generalizability of the results of randomized trials. Archives of Internal Medicine, 168 (2), 133-135.
36. Dekkers, O. M., von Elm, E., Algra, A., Romijn, J. A., &, Vandenbroucke, J. P., (2010) How to assess the external validity of therapeutic trials: a conceptual approach. International Journal of Epidemiology, 39 (1), 89-94.
37. Fine, P. E. M., (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet, 346 (8986), 1339-1345.
38. Materson, B. J., Reda, D. J., Cushman, W. C., et al. (1993) Single-drug therapy for hypertension in men: a comparison of 6 antihypertensive agents with placebo. New England Journal of Medicine, 328 (13), 914-921.
39. Pablos-Mendez, A., Barr, R. G., &, Shea, S., (1998) Run-in periods in randomized trials: implications for the application of results in clinical practice. Journal of the American Medical Association, 279 (3), 222-225.
40. Popper, K. R., (1963) Conjectures and refutations. London: Routledge & Kegan Paul.
41. Fuller, J., (2013) Argumentation and rhetoric: how clinical practice guidelines think. Journal of Evaluation in Clinical Practice, 19 (3), 433-441.
42. Cartwright, N., (2011) A philosopher's view of the long road from RCTs to effectiveness. Lancet, 377 (9775), 1400-1401.
43. Cartwright, N., &, Munro, E., (2010) The limitations of randomized controlled trials in predicting effectiveness. Journal of Evaluation in Clinical Practice, 16 (2), 260-266.